Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
03 Sep 2024
Historique:
accepted: 17 06 2024
received: 18 09 2023
revised: 12 06 2024
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: aheadofprint

Résumé

Genetic studies have identified numerous regions associated with plasma fibrinogen levels in Europeans, yet missing heritability and limited inclusion of non-Europeans necessitates further studies with improved power and sensitivity. Compared with array-based genotyping, whole genome sequencing (WGS) data provides better coverage of the genome and better representation of non-European variants. To better understand the genetic landscape regulating plasma fibrinogen levels, we meta-analyzed WGS data from the NHLBI's Trans-Omics for Precision Medicine (TOPMed) program (n=32,572), with array-based genotype data from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (n=131,340) imputed to the TOPMed or Haplotype Reference Consortium panel. We identified 18 loci that have not been identified in prior genetic studies of fibrinogen. Of these, four are driven by common variants of small effect with reported MAF at least 10 percentage points higher in African populations. Three signals (SERPINA1, ZFP36L2, and TLR10) contain predicted deleterious missense variants. Two loci, SOCS3 and HPN, each harbor two conditionally distinct, non-coding variants. The gene region encoding the fibrinogen protein chain subunits (FGG;FGB;FGA), contains 7 distinct signals, including one novel signal driven by rs28577061, a variant common in African ancestry populations but extremely rare in Europeans (MAFAFR=0.180; MAFEUR=0.008). Through phenome-wide association studies in the VA Million Veteran Program, we found associations between fibrinogen polygenic risk scores and thrombotic and inflammatory disease phenotypes, including an association with gout. Our findings demonstrate the utility of WGS to augment genetic discovery in diverse populations and offer new insights for putative mechanisms of fibrinogen regulation.

Identifiants

pubmed: 39226462
pii: 517658
doi: 10.1182/blood.2023022596
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society of Hematology.

Auteurs

Jennifer E Huffman (JE)

Palo Alto VA Institute for Research, VA Palo Alto Heath Care System, United States.

Jayna Nicholas (J)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Julie Hahn (J)

School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States.

Adam S Heath (AS)

University of Texas Health Science Center at Houston, Houston, Texas, United States.

Laura M Raffield (LM)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Lisa R Yanek (LR)

Johns Hopkins Medical Institutions, Baltimore, Maryland, United States.

Jennifer A Brody (JA)

Department of Veterans Affairs Office of Research and Development, United States.

Florian Thibord (F)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Laura Almasy (L)

University of Pennsylvania, Philadelphia, Pennsylvania, United States.

Traci M Bartz (TM)

Department of Veterans Affairs Office of Research and Development, United States.

Lawrence F Bielak (LF)

University of Michigan, Ann Arbor, Michigan, United States.

Russell P Bowler (RP)

National Jewish Health, Denver, Colorado, United States.

German D Carrasquilla (GD)

University of Copenhagen, Copenhagen, Denmark.

Daniel I Chasman (DI)

Department of Veterans Affairs Office of Research and Development, United States.

Ming-Huei Chen (MH)

Department of Veterans Affairs Office of Research and Development, United States.

David B Emmert (DB)

Eurac Research, Bolzano, Italy.

Mohsen Ghanbari (M)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Jeffrey Haessler (J)

Department of Veterans Affairs Office of Research and Development, United States.

Jouke J Hottenga (JJ)

Department of Veterans Affairs Office of Research and Development, United States.

Marcus E Kleber (ME)

Department of Veterans Affairs Office of Research and Development, United States.

Ngoc-Quynh Le (NQ)

Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.

Jiwon Lee (J)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Joshua P Lewis (JP)

Department of Veterans Affairs Office of Research and Development, United States.

Ruifang Li-Gao (R)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Jian'an Luan (J)

University of Cambridge, Cambridge, United Kingdom.

Anni Liisi Malmberg (AL)

University of Helsinki, Helsinki, Finland.

Massimo Mangino (M)

Department of Veterans Affairs Office of Research and Development, United States.

Riccardo Marioni (R)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Angel Martinez-Perez (A)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Nathan Pankratz (N)

Department of Veterans Affairs Office of Research and Development, United States.

Ozren Polasek (O)

Department of Veterans Affairs Office of Research and Development, United States.

Anne Richmond (A)

University of Edinburgh, Edinburgh, United Kingdom.

Benjamin A T Rodriguez (BAT)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Jerome I Rotter (JI)

The Framingham Heart Study, United States.

Maristella Steri (M)

Department of Veterans Affairs Office of Research and Development, United States.

Pierre Suchon (P)

AP-HM, Marseille, France.

Stella Trompet (S)

LUMC, Leiden, Netherlands.

Stefan Weiss (S)

University Medicine Greifswald, Greifswald, Germany.

Marjan Zare (M)

School of Public Health, Imperial College London, London, United Kingdom.

Paul L Auer (PL)

The Framingham Heart Study, United States.

Michael Cho (M)

The Framingham Heart Study, United States.

Paraskevi Christofidou (P)

Kings College London, London, United Kingdom.

Gail Davies (G)

Department of Veterans Affairs Office of Research and Development, United States.

Eco Jc de Geus (EJ)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Jean-François Deleuze (JF)

CEA Fontenay-Aux-Roses, Evry, France.

Graciela E Delgado (GE)

Department of Veterans Affairs Office of Research and Development, United States.

Lynette Ekunwe (L)

Department of Veterans Affairs Office of Research and Development, United States.

Nauder Faraday (N)

Department of Veterans Affairs Office of Research and Development, United States.

Martin Gogele (M)

Eurac Research, Bolzano, Italy.

Andreas Greinacher (A)

The Framingham Heart Study, United States.

He Gao (H)

School of Public Health, Imperial College London, London, United Kingdom.

Tom E Howard (TE)

Department of Veterans Affairs Office of Research and Development, United States.

Peter K Joshi (PK)

Department of Veterans Affairs Office of Research and Development, United States.

Tuomas O Kilpeläinen (TO)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Jari Lahti (J)

Department of Veterans Affairs Office of Research and Development, United States.

Allan Linneberg (A)

Department of Veterans Affairs Office of Research and Development, United States.

Silvia Naitza (S)

IRGB, CNR, Monserrato-Cagliari, Italy.

Raymond Noordam (R)

Department of Veterans Affairs Office of Research and Development, United States.

Ferran Paüls Vergés (FP)

Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.

Stephen S Rich (SS)

Department of Veterans Affairs Office of Research and Development, United States.

Frits R Rosendaal (FR)

Department of Veterans Affairs Office of Research and Development, United States.

Igor Rudan (I)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Kathleen A Ryan (KA)

Department of Veterans Affairs Office of Research and Development, United States.

Juan Carlos Carlos Souto (JCC)

Department of Veterans Affairs Office of Research and Development, United States.

Frank J A van Rooij (FJA)

Erasmus University Medical Center, Rotterdam, Netherlands.

Heming Wang (H)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Wei Zhao (W)

University of Michigan, ANN ARBOR, Michigan, United States.

Lewis Becker (L)

Department of Veterans Affairs Office of Research and Development, United States.

Andrew Beswick (A)

Department of Veterans Affairs Office of Research and Development, United States.

Michael R Brown (MR)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Brian Cade (B)

Department of Veterans Affairs Office of Research and Development, United States.

Harry Campbell (H)

Department of Veterans Affairs Office of Research and Development, United States.

Kelly Cho (K)

VA Boston Healthcare System, Boston, Massachusetts, United States.

James Crapo (J)

Department of Veterans Affairs Office of Research and Development, United States.

Joanne Curran (J)

School of Medicine, University of Texas Rio Grande Valley, Brownsville, Texas, United States.

Moniek P M de Maat (MPM)

Erasmus Medical Center Rotterdam, Rotterdam, Netherlands.

Margaret F Doyle (MF)

Larner College of Medicine at the University of Vermont, Colchester, Vermont, United States.

Paul Elliott (P)

Imperial College London, London, United Kingdom.

James S Floyd (JS)

University of Washington, Seattle, Washington, United States.

Christian Fuchsberger (C)

Eurac Research, Bolzano, Italy.

Niels Grarup (N)

University of Copenhagen, Copenhagen, Denmark.

Xiuqing Guo (X)

Department of Veterans Affairs Office of Research and Development, United States.

Sarah Harris (S)

Karolinska Institutet, Center for Molecular Medicine, Sweden.

Lifang Hou (L)

Department of Veterans Affairs Office of Research and Development, United States.

Ivana Kolcic (I)

Department of Veterans Affairs Office of Research and Development, United States.

Charles Kooperberg (C)

FHCRC, Seattle, United States.

Cristina Menni (C)

Kings College London, London, United Kingdom.

Matthias Nauck (M)

University Medicine Greifswald, Greifswald, Germany.

Jeffrey R O'Connell (JR)

Department of Veterans Affairs Office of Research and Development, United States.

Valeria Orru (V)

Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy.

Bruce M Psaty (BM)

Department of Veterans Affairs Office of Research and Development, United States.

Katri Räikkönen (K)

Department of Veterans Affairs Office of Research and Development, United States.

Jennifer A Smith (JA)

University of Michigan, Ann Arbor, Michigan, United States.

Jose Manuel Soria (JM)

Department of Veterans Affairs Office of Research and Development, United States.

David Stott (D)

University of Glasgow, Glasgow, United Kingdom.

Astrid van Hylckama Vlieg (A)

Leiden University Medical Center, Leiden, Netherlands.

Hugh Watkins (H)

University of Oxford, Oxford, United Kingdom.

Gonneke Willemsen (G)

Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Peter Wf Wilson (PW)

Atlanta VA Health Care System, Decatur, Georgia, United States.

Yoav Ben-Shlomo (Y)

University of Bristol, Bristol, United Kingdom.

John Blangero (J)

University of Texas Rio Grande Valley, Brownsville, United States.

Dorret Boomsma (D)

Vrije Universiteit, Amsterdam, Amsterdam, Netherlands.

Simon R Cox (SR)

University of Edinburgh, Edinburgh, United Kingdom.

Abbas Dehghan (A)

Imperial College London, London, United Kingdom.

Johan G Eriksson (JG)

University of Helsinki, Helsinki, Finland.

Edoardo Fiorillo (E)

Consiglio Nazionale delle Ricerche, Lanusei, Italy.

Myriam Fornage (M)

University of Texas Health Science Center at Houston, Houston, Texas, United States.

Torben Hansen (T)

University of Copenhagen, Copenhagen, Denmark.

Caroline Hayward (C)

University of Edinburgh, Edinburgh, United Kingdom.

Mohammad Arfan Ikram (MA)

Erasmus MC, Rotterdam, Netherlands.

J Wouter Jukema (JW)

Leiden University Medical Center, Leiden, Netherlands.

Sharon Kardia (S)

University of Michigan, Ann Arbor, Michigan, United States.

Leslie Lange (L)

University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States.

Winfried Maerz (W)

Synlab MVZ Heidelberg, Eppelheim, Germany.

Rasika Mathias (R)

Johns Hopkins University, Baltimore, Maryland, United States.

Braxton D Mitchell (BD)

University of Maryland, Baltimore, Maryland, United States.

Dennis O Mook-Kanamori (DO)

Leiden University Medical Center, Leiden, Netherlands.

Pierre-Emmanuel Morange (PE)

CHU Timone - Marseille France, Marseille, France.

Oluf Pedersen (O)

University of Copenhagen, Copenhagen, Denmark.

Susan Redline (S)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Alex P Reiner (AP)

Fred Hutchinson Cancer Center, Seattle, Washington, United States.

Paul M Ridker (PM)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Edwin K Silverman (EK)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Tim D Spector (TD)

king's College London, London, United Kingdom.

Uwe Volker (U)

University Medicine Greifswald, Greifswald, Germany.

Nick Wareham (N)

University of Cambridge, Cambridge, United Kingdom.

James Wilson (J)

University of Edinburgh, Edinburgh, United Kingdom.

Jie Yao (J)

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.

David-Alexandre Tregouet (DA)

INSERM UMR 1219, Bordeaux Population Health Research Center, Bordeaux, France.

Andrew D Johnson (AD)

National Heart, Lung, and Blood Institute, The Framingham Heart Study, Framingham, Massachusetts, United States.

Alisa S Wolberg (AS)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Paul S de Vries (PS)

University of Texas Health Science Center at Houston, Houston, Texas, United States.

Maria Sabater-Lleal (M)

Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.

Alanna Morrison (A)

University of Texas at Houston Health Science Center, Houston, Texas, United States.

Nicholas L Smith (NL)

Department of Veterans Affairs Office of Research and Development, United States.

Classifications MeSH